Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2019-11-15 | 2020-01-06 | 98922 |
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-01-13 | 2020-02-26 | 103178 |
| DIOVAN | 320MG | TABLET | Resolved | 2020-04-22 | 2020-05-05 | 112809 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-03-20 | 2019-07-23 | 79017 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-11-08 | 2019-12-19 | 98249 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-12-19 | 2020-04-17 | 101771 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| RITALIN 20MG | 20MG | TABLET | Resolved | 2017-06-07 | 2017-08-31 | 12261 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-01-08 | 2018-02-08 | 35254 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-03-16 | 2022-04-06 | 156780 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-05-04 | 2022-08-05 | 159990 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |